MuIdentification of plitidepsin as potent inhibitor of SARS-CoV-2-induced cytopathic effect after a drug repurposing screen.

by on 3 de maig de 2021 with No hi ha comentaris
  • Rodon, J., Muñoz-Basagoiti, J., Perez-Zsolt, D., Noguera-Julian, M., Paredes, R., Mateu, L., Blanco, J., Clotet, B., . . . Izquierdo-Useros, N. (2021). Identification of plitidepsin as potent inhibitor of SARS-CoV-2-induced cytopathic effect after a drug repurposing screen. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.646676

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *